Literature DB >> 21163876

Preliminary results of the luna aneurysm embolization system in a rabbit model: a new intrasaccular aneurysm occlusion device.

S C Kwon1, Y H Ding, D Dai, R Kadirvel, D A Lewis, D F Kallmes.   

Abstract

BACKGROUND AND
PURPOSE: Recent advances in endovascular devices have been aimed at providing high density, mesh-like metallic materials across the aneurysm neck, in place of coil technology. Therefore our aim was to report the in vivo preclinical performance of a self-expanding intrasaccular embolization device.
MATERIALS AND METHODS: Elastase-induced aneurysms were created in 12 rabbits. Each aneurysm was embolized with a Luna AES. DSA was performed preimplantation; 5, 10, and 30 minutes postimplantation; and at 1 month in 12 rabbits and at 3 months in 8 rabbits. Early postimplantation intra-aneurysmal flow was graded as unchanged, moderately diminished, or completely absent. One- and 3-month DSAs were graded by using a 3-point scale (complete, near-complete, or incomplete occlusion). Aneurysms were harvested for gross and microscopic histologic evaluation at 1 month (n = 4) and at 3 months (n = 8). Tissues within the aneurysm dome and across the aneurysm neck were assessed by using HE staining.
RESULTS: Ten (83%) of 12 aneurysms demonstrated complete cessation of flow within 30 minutes of device implantation. At 1-month follow-up, 10 (83%) of 12 aneurysms were completely occluded. At 3 months, 7 of 8 (88%) aneurysms remained completely occluded. One-month gross examination in 4 rabbits demonstrated that membranous tissue completely covered the device in 3 subjects (75%). Microscopic examination showed that 3 aneurysms had loose connective tissue filling the aneurysm cavity. Three-month gross and microscopic examinations demonstrated membranous tissue completely covering the device, loose connective tissue filling the aneurysm cavity, and neointima formation crossing the aneurysm neck in 8 of 8 (100.0%) subjects.
CONCLUSIONS: The Luna AES achieved high rates of complete angiographic occlusion and showed promising histologic findings in the rabbit aneurysm model.

Entities:  

Mesh:

Year:  2010        PMID: 21163876      PMCID: PMC8013104          DOI: 10.3174/ajnr.A2314

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  16 in total

1.  1999 ARRS Executive Council Award. Creation of saccular aneurysms in the rabbit: a model suitable for testing endovascular devices. American Roentgen Ray Society.

Authors:  T A Altes; H J Cloft; J G Short; A DeGast; H M Do; G A Helm; D F Kallmes
Journal:  AJR Am J Roentgenol       Date:  2000-02       Impact factor: 3.959

2.  Modified histologic technique for processing metallic coil-bearing tissue.

Authors:  Daying Dai; Yong Hong Ding; Mark A Danielson; Ramanathan Kadirvel; Debra A Lewis; Harry J Cloft; David F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

3.  A multicenter study of 705 ruptured intracranial aneurysms treated with Guglielmi detachable coils.

Authors:  Sophie Gallas; Anne Pasco; Jean-Philippe Cottier; Jean Gabrillargues; Jacques Drouineau; Christophe Cognard; Denis Herbreteau
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

4.  Intra-venous digital subtraction angiography: an alternative method to intra-arterial digital subtraction angiography for experimental aneurysm imaging.

Authors:  Yong Hong Ding; Daying Dai; Debra A Lewis; Mark A Danielson; Ramanathan Kadirvel; Jayawant N Mandrekar; Harry J Cloft; David F Kallmes
Journal:  Neuroradiology       Date:  2005-08-25       Impact factor: 2.804

5.  Natural history of the neck remnant of a cerebral aneurysm treated with the Guglielmi detachable coil system.

Authors:  M Hayakawa; Y Murayama; G R Duckwiler; Y P Gobin; G Guglielmi; F Viñuela
Journal:  J Neurosurg       Date:  2000-10       Impact factor: 5.115

6.  Endovascular coil embolization of intracranial aneurysms: important factors related to rates and outcomes of incomplete occlusion.

Authors:  Max K Kole; David M Pelz; Paul Kalapos; Donald H Lee; Irene B Gulka; Stephen P Lownie
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

7.  Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils.

Authors:  Jean Raymond; François Guilbert; Alain Weill; Stavros A Georganos; Louis Juravsky; Anick Lambert; Julie Lamoureux; Miguel Chagnon; Daniel Roy
Journal:  Stroke       Date:  2003-05-29       Impact factor: 7.914

8.  Treatment of wide-necked intracranial aneurysms with a novel self-expanding two-zonal endovascular stent device.

Authors:  Frank Ahlhelm; Christian Roth; Ralf Kaufmann; Gernot Schulte-Altedorneburg; Bernd F M Romeike; Wolfgang Reith
Journal:  Neuroradiology       Date:  2007-08-17       Impact factor: 2.804

9.  A new endoluminal, flow-disrupting device for treatment of saccular aneurysms.

Authors:  David F Kallmes; Yong Hong Ding; Daying Dai; Ramanathan Kadirvel; Debra A Lewis; Harry J Cloft
Journal:  Stroke       Date:  2007-07-05       Impact factor: 7.914

10.  An original flow diversion device for the treatment of intracranial aneurysms: evaluation in the rabbit elastase-induced model.

Authors:  Chander Sadasivan; Liliana Cesar; Jaehoon Seong; Audrey Rakian; Qing Hao; Fermin O Tio; Ajay K Wakhloo; Baruch B Lieber
Journal:  Stroke       Date:  2009-01-15       Impact factor: 7.914

View more
  9 in total

Review 1.  From bench to bedside: utility of the rabbit elastase aneurysm model in preclinical studies of intracranial aneurysm treatment.

Authors:  Waleed Brinjikji; Yong H Ding; David F Kallmes; Ramanathan Kadirvel
Journal:  J Neurointerv Surg       Date:  2015-04-22       Impact factor: 5.836

2.  The Woven EndoBridge cerebral aneurysm embolization device (WEB II): initial clinical experience.

Authors:  Joachim Klisch; Vojtech Sychra; Christoph Strasilla; Thomas Liebig; David Fiorella
Journal:  Neuroradiology       Date:  2011-05-27       Impact factor: 2.804

3.  Middle Cerebral Artery Aneurysm "Neck Overhang": Decreased Postclipping Residual Using the Intersecting Clipping Technique.

Authors:  Stavros Dimitriadis; Fares Qeadan; Christopher L Taylor; Howard Yonas; Andrew P Carlson
Journal:  Oper Neurosurg (Hagerstown)       Date:  2018-10-01       Impact factor: 2.703

Review 4.  Recurrence of endovascularly and microsurgically treated intracranial aneurysms-review of the putative role of aneurysm wall biology.

Authors:  Serge Marbacher; Mika Niemelä; Juha Hernesniemi; Juhana Frösén
Journal:  Neurosurg Rev       Date:  2017-08-17       Impact factor: 3.042

5.  Rabbit Elastase Aneurysm Model Mimics the Recurrence Rate of Human Intracranial Aneurysms following Platinum Coil Embolization.

Authors:  Y-H Ding; S Ghozy; D Dai; W Brinjikji; D F Kallmes; R Kadirvel
Journal:  AJNR Am J Neuroradiol       Date:  2022-04-28       Impact factor: 4.966

6.  Endosaccular Flow Disruption: A New Frontier in Endovascular Aneurysm Management.

Authors:  Adam A Dmytriw; Mohamed M Salem; Victor X D Yang; Timo Krings; Vitor M Pereira; Justin M Moore; Ajith J Thomas
Journal:  Neurosurgery       Date:  2020-02-01       Impact factor: 4.654

Review 7.  The evolution of intracranial aneurysm treatment techniques and future directions.

Authors:  Keng Siang Lee; John J Y Zhang; Vincent Nguyen; Julian Han; Jeremiah N Johnson; Ramez Kirollos; Mario Teo
Journal:  Neurosurg Rev       Date:  2021-04-23       Impact factor: 2.800

8.  Lumen-oriented versus wall-oriented treatment strategies for intracranial aneurysms - A systematic review of suggested therapeutic concepts.

Authors:  Basil E Grüter; Fabio von Faber-Castell; Serge Marbacher
Journal:  J Cereb Blood Flow Metab       Date:  2021-11-19       Impact factor: 6.960

9.  Treatment of experimental aneurysms with a GPX embolic agent prototype: preliminary angiographic and histological results.

Authors:  Frederik Fries; Toshiki Tomori; Walter J Schulz-Schaeffer; Joshua Jones; Umut Yilmaz; Michael Kettner; Andreas Simgen; Wolfgang Reith; Ruben Mühl-Benninghaus
Journal:  J Neurointerv Surg       Date:  2021-05-04       Impact factor: 5.836

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.